Table 1.
Characteristic | All Patients (n=90) |
---|---|
Age mean (SD) | 58.1 (14.4) |
Race: White | 82 (91.1%) |
Male (%) | 53 (58.9%) |
Type of Transplant | |
Autologous HCT | 30 (33.3%) |
Myeloablative Allogeneic HCT | 30 (33.3%) |
Reduced Intensity Allogeneic HCT | 30 (33.3%) |
Diagnosis (%) | |
ALL | 7 (7.8%) |
AML/MDS | 45 (50.0%) |
MF/CML | 2 (2.2%) |
Lymphoma | 23 (25.6%) |
MM | 9 (10%) |
Relationship status | |
Married | 60 (66.7%) |
Divorced | 7 (7.8%) |
Single | 12 (13.3%) |
Widowed | 11 (12.2%) |
Education | |
High school | 23 (25.6%) |
College | 46 (51.1%) |
Post graduate | 21 (23.3%) |
Income | |
<25,000 | 11 (12.2%) |
25,000–50,000 | 14 (15.6%) |
51,000–100,000 | 27 (30.0%) |
101,000–150,000 | 17 (18.9%) |
>150,000 | 12 (13.3%) |
Missing | 9 (10.0%) |
HCT-Comorbidity Index (HCT-CI) median (range) | 1.0 (0–7) |
ALL = Acute lymphoblastic leukemia, AML = Acute myeloid leukemia, MDS = Myelodysplastic syndrome, MF = Myelofibrosis, CML = Chronic myeloid leukemia, MM = Multiple myeloma, HCT: Hematopoietic stem cell transplantation, SD = Standard deviation.